The report “Laser Capture Microdissection Market by Product (Instruments, Consumables, Software, Services), System Type (Ultraviolet, Infrared, Immunofluorescence), Application (R&D, Diagnostics) – Global Forecast to 2029″ projects the market to reach USD 306 million by 2029, up from USD 184 million in 2024. This represents a compound annual growth rate (CAGR) of 10.6% over the forecast period from 2024 to 2029.
Market Overview:
The laser capture microdissection market is set for substantial growth due to increased adoption across various research fields, advancements in sample preparation techniques, and the rising demand for personalized medicine. The consumables segment, in particular, held the largest market share in 2023, driven by these factors.
Growth Driving Factors:
The growth of the LCM market is propelled by the increasing demand for laser capture microdissection in cancer research and the collaborations between academic institutions, research organizations, and industry players. Continuous advancements in laser technology, microscopy, and automation are also key contributors, enhancing the precision, efficiency, and ease of use of LCM systems.
Key Players:
Prominent companies in the LCM market include:
- Thermo Fisher Scientific Inc. (US)
- Danaher Corporation (US)
- Carl Zeiss AG (Germany)
- F. Hoffmann-La Roche AG (Switzerland)
- Standard BioTools (US)
These key players are leveraging strategies such as mergers and acquisitions, investments, partnerships, collaborations, and new product developments to strengthen their market positions.
Market Segmentation:
- By product, the laser capture microdissection market has been further categorized as instruments, consumables, software and services. The consumables segment held the largest share of the global laser capture microdissection market in 2023. This can be attributed to increasing adoption of LCM technology across various research fields, advancements in sample preparation techniques, and the rising demand for personalized medicine.
- Based on application, the global laser capture microdissection market has been segmented into research & development, diagnostics, and other applications. The research & development segment held the largest market share in 2023.
Regional Insights: The North American market has shown significant growth, primarily due to the large pharmaceutical and biopharmaceutical industries, increased R&D expenditure, stringent regulations, and the presence of major LCM product providers in the US and Canada.
Recent Industry Developments:
- Danaher Corporation (US) acquired Abcam plc (UK) in August 2023, a move that strengthens Danaher’s position in the life sciences segment and accelerates drug discovery.
- Crown Bioscience International (US), a JSR Life Sciences company, acquired Indivumed Services GmbH & Co. KG (Germany) in March 2023, enhancing its drug discovery and development services.
Conclusion:
The laser capture microdissection market is on an upward trajectory, driven by technological advancements and increased demand across various research and diagnostic applications. With significant growth anticipated by 2029, this market offers promising opportunities for stakeholders and investors.